ExpertiseUpdated on 29 October 2025
Advisory services on the implementation of 3D printing technology in public and private hospitals.
Medical Advisor on 3D Printing Integration in Clinical Environments. at Eureqa 3D
Cáceres, Spain
About
I advise and assist surgeons and management teams (CEO, managing directors) in exploring all 3D printing technology options to identify the workflow that best suits their team or hospital.
Field
- Donor institution with a ready PM approach
- Receiver institution with a need to adopt a PM approach
- Screening & early detection programs (risk stratification, predictive tools)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Clinical decision support systems for personalised medicine
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
- Reimbursement-ready approaches (integration with public health insurance systems)
- Cultural/organisational change approaches (staff training, workflow redesign)
- Patient engagement & empowerment strategies (self-management tools, shared decision-making)
- Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)
- Adaptation of an existing PM solution to local context (language, IT environment, regulations)
- Partial adoption of a PM solution (testing selected modules/components)
- Full adoption/acquisition of a PM solution into clinical practice
Organisation
Similar opportunities
Expertise
Citogenetics and Functional Genomics
- Receiver institution with a need to adopt a PM approach
- Clinical decision support systems for personalised medicine
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Screening & early detection programs (risk stratification, predictive tools)
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
Inês Costa
Research Manager at Universidade de Coimbra - Faculdade de Coimbra
Coimbra, Portugal
Expertise
Advancing Personalized Medicine Through Integrative Research and Clinical Excellence
- Receiver institution with a need to adopt a PM approach
- Clinical decision support systems for personalised medicine
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Partial adoption of a PM solution (testing selected modules/components)
- Tools for secure data sharing & secondary use (pseudonymisation, FAIR data)
- Screening & early detection programs (risk stratification, predictive tools)
- Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
- Cultural/organisational change approaches (staff training, workflow redesign)
- Data integration & interoperability solutions (EHRs, registries, data platforms)
- Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
- Patient engagement & empowerment strategies (self-management tools, shared decision-making)
- Adaptation of an existing PM solution to local context (language, IT environment, regulations)
- Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)
Inês Costa
Research Manager at Universidade de Coimbra - Faculdade de Coimbra
Coimbra, Portugal
Expertise
Doctor of Medicine, Cardiology specialist
- Clinical decision support systems for personalised medicine
- Theranostics (combined diagnostic + therapeutic approaches)
- Full adoption/acquisition of a PM solution into clinical practice
- Patient management systems (decision-support tools, clinical workflows)
- Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
- Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
- Implementation of CE-marked digital health solutions (AI algorithms, software, apps)
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
Filonid Aliu
MD, Chief Medical Officer at PARAL at PARAL
Liverpool, United Kingdom